10 Best Value Stocks to Buy According to Billionaires
The H1 2025 has been a roller coaster ride for the investors. During the initial months of the year, the benchmarks touched record highs, according to Bank of America Private Bank.
Gilead Sciences Inc. (GILD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 5,451,143 | $610,800,573 | +3% | 0.92% |
| 2. | Citadel Investment Group Ken Griffin | 5,373,962 | $602,152,442 | +15% | 0.11% |
| 3. | Millennium Management Israel Englander | 2,538,504 | $284,439,373 | +272% | 0.15% |
| 4. | Holocene Advisors Brandon Haley | 2,307,871 | $258,596,946 | 0.75% | |
| 5. | AQR Capital Management Cliff Asness | 1,864,670 | $207,369,860 | +3% | 0.21% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.92 | 10,000 | $999,150.00 | 88,173 | 2015-02-06 | Filing | |
| $43.05 | 10,000 | $430,493.00 | 69,458 | 2013-02-28 | Filing | |
| $44.00 | 10,000 | $439,955.00 | 26,097 | 2012-02-22 | Filing | |
| $38.60 | 8,704 | $335,974.40 | 12,800 | 2010-05-04 | Filing | |
| $38.59 | 4,096 | $158,064.64 | 4,096 | 2010-05-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $111.15 | 600 | $66,688.02 | 615,725 | 2025-06-30 | Filing | |
| $110.40 | 9,400 | $1,037,795.72 | 616,325 | 2025-06-30 | Filing | |
| $110.17 | 2,500 | $275,425.00 | 165,110 | 2025-06-16 | Filing | |
| $110.17 | 3,000 | $330,510.00 | 120,168 | 2025-06-16 | Filing | |
| $110.96 | 3,584 | $397,696.05 | 620,268 | 2025-05-30 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 969,807 | $107,522,447 | 1.52% | |
| 2. | 33,841 | $3,751,996 | 0.77% | |
| 3. | 13,997 | $1,551,817 | 0.22% | |
| 4. | 219 | $24,281 | 0% | |
| 5. | 135 | $14,991 | 0.01% |
News See All
10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio
Ray Dalio began his investing journey at just 12 years old and went on to gain experience at institutions such as the New York Stock Exchange, Dominick & Dominick LLC, and Shearson Hayden Stone.
Gilead, Kymera Partner in $750M Deal to Develop Novel Molecular Glue Degraders for Cancer
Gilead Sciences Inc. (NASDAQ:GILD) is one of the undervalued S&P 500 stocks to buy according to hedge funds.
10 Undervalued S&P 500 Stocks to Buy According to Hedge Funds
On June 24, Paul Hickey, Bespoke Investment Group co-founder, joined 'Squawk Box' on CNBC to suggest that periods of widespread fear often present good buying opportunities.
Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern
Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now.
12 Best Healthcare Stocks to Buy Now
Healthcare companies in the US are facing policy headwinds under President Donald Trump's Administration.
Goldman Sachs Reiterates a Hold Rating on Gilead Sciences (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Goldman Sachs analyst Salveen Richter reiterated a Hold rating on Gilead Sciences, Inc.
RBC Capital Lifts Gilead Sciences (GILD) PT to $95 On Insights From a 2022 Patient Survey
Gilead Sciences Inc. (NASDAQ:GILD) is one of the 11 most profitable NASDAQ stocks to buy now.
11 Most Profitable NASDAQ Stocks to Buy Now
Earlier on May 30, Siebert Financial CIO Mark Malek appeared on CNBC to discuss the tariff headwinds swirling around the markets and which sectors could then rise above the noise and continue to perform...
11 Best Drug Stocks to Buy According to Hedge Funds
Health and Human Services Secretary Robert F. Kennedy Jr.
Billionaire Hedge Funds
